Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022
July 21 2022 - 4:05PM
Exagen Inc. (Nasdaq: XGN), a leading provider of
autoimmune testing solutions, will release financial results for
the quarter ended June 30, 2022, after the market close on
Thursday, August 4, 2022. Ron Rocca, Exagen’s President and Chief
Executive Officer, Kamal Adawi, Chief Financial Officer, and Mark
Hazeltine, Chief Operating Officer, will host a conference call to
review the Company’s results at 4:30 PM ET (1:30 PM PT).
Interested parties may access the conference call by dialing
(404) 267-0369 (U.S.) or (888) 437-3179 (international).
Participants wishing to access the call via webcast should use the
link posted on the Exagen investor relations website at
investors.exagen.com.
A replay of the conference call will be available until
Thursday, August 18, 2022, at 11:59 PM ET (8:59 PM PT). Interested
parties may access the replay of the conference call by dialing
(201) 612-7415 (U.S.) or (877) 660-6853 (international) using
passcode 13731768. Additionally, a recording of the webcast will be
available using the link on the Exagen investor relations website
approximately one hour after the call concludes.
About Exagen Inc.
Exagen (Nasdaq: XGN) is a leading provider of autoimmune
diagnostic, prognostic, and monitoring testing solutions. Exagen is
a patient focused, discovery driven organization built on the
success of AVISE® testing and is investing in its product pipeline
to support patients throughout their autoimmune diagnosis and
treatment journeys. The goal at Exagen is to assist patients,
physicians, and payors by enabling precision medicine. Exagen is
located in San Diego County with clinical and research and
development laboratories in Vista, CA.
For more information, please visit Exagen.com and follow
@ExagenInc on Twitter.
CONTACTS:
Investor RelationsExagen Inc.Ryan
Douglasrdouglas@exagen.com760.560.1525
CompanyExagen Inc.Kamal Adawi, Chief Financial
Officerkadawi@exagen.com760.477.5514
Exagen (NASDAQ:XGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exagen (NASDAQ:XGN)
Historical Stock Chart
From Apr 2023 to Apr 2024